Back
ProShares Ultra Gold Vs. Vaxcyte Industry Stock Comparison
Buy
69
UGL
ProShares Ultra Gold
Last Price:
$135.87
Seasonality Move:
-1.85%
Sell
13
PCVX
Vaxcyte
Last Price:
$31.23
Seasonality Move:
12.17%
Buy
69
ProShares Ultra Gold (UGL)
is a Buy
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $131.04. The Score for UGL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
UGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $131.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
UGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.66 | Buy |
Relative Strength Index (14 RSI): | 64.37 | Buy |
Chaikin Money Flow: | 823099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (115.49 - 126.29) | Buy |
Bollinger Bands (100): | (94.72 - 117.28) | Buy |
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.98 | Sell |
Relative Strength Index (14 RSI): | 17.69 | Sell |
Chaikin Money Flow: | -2100322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.34 - 77.94) | Sell |
Bollinger Bands (100): | (62.86 - 95.72) | Sell |
UGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.98 | Buy |
20-day SMA: | 122.7 | Buy |
50-day SMA: | 115.95 | Buy |
200-day SMA: | 97.89 | Buy |
8-day EMA: | 123.93 | Buy |
20-day EMA: | 121.86 | Buy |
50-day EMA: | 116.1 | Buy |
200-day EMA: | 99.7 | Buy |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.2 | Sell |
20-day SMA: | 54.57 | Sell |
50-day SMA: | 70.52 | Sell |
200-day SMA: | 87.15 | Sell |
8-day EMA: | 34.99 | Sell |
20-day EMA: | 48.66 | Sell |
50-day EMA: | 64.58 | Sell |
200-day EMA: | 79.18 | Sell |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.44 per share.
ProShares Ultra Gold Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vaxcyte Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |